The present systematic review summarizes the current literature on reported physiological role of CGRP reflected by vascular changes following infusion of h-α-CGRP in healthy volunteers and individuals diagnosed with migraine, discuss the physiological and pathophysiological effects based on the reported adverse events (AEs), and highlights potential risks when targeting CGRP signaling pathway. This evidence concerns the gene CALCA and migraine disorder.